

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 6.41974604 |
| 2 | ribosomal small subunit assembly (GO:0000028) | 5.26201093 |
| 3 | proline biosynthetic process (GO:0006561) | 4.87822915 |
| 4 | proteasome assembly (GO:0043248) | 4.79639066 |
| 5 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.78583780 |
| 6 | peptidyl-arginine omega-N-methylation (GO:0035247) | 4.52463464 |
| 7 | oxidative phosphorylation (GO:0006119) | 4.47459207 |
| 8 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.39754789 |
| 9 | ATP synthesis coupled proton transport (GO:0015986) | 4.39754789 |
| 10 | maturation of SSU-rRNA (GO:0030490) | 4.36529931 |
| 11 | DNA unwinding involved in DNA replication (GO:0006268) | 4.34345686 |
| 12 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.22952140 |
| 13 | viral transcription (GO:0019083) | 4.22932024 |
| 14 | regulation of translational fidelity (GO:0006450) | 4.22251387 |
| 15 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 4.21452715 |
| 16 | nucleobase biosynthetic process (GO:0046112) | 4.20670352 |
| 17 | formation of translation preinitiation complex (GO:0001731) | 4.18740443 |
| 18 | termination of RNA polymerase III transcription (GO:0006386) | 4.17343309 |
| 19 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.17343309 |
| 20 | purine nucleobase biosynthetic process (GO:0009113) | 4.13852750 |
| 21 | translational termination (GO:0006415) | 4.13045012 |
| 22 | ribosomal small subunit biogenesis (GO:0042274) | 4.10478462 |
| 23 | regulation of translational termination (GO:0006449) | 4.00654603 |
| 24 | protein maturation by protein folding (GO:0022417) | 3.98423274 |
| 25 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.96719841 |
| 26 | translational elongation (GO:0006414) | 3.94671423 |
| 27 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.93445706 |
| 28 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.90672606 |
| 29 | histone arginine methylation (GO:0034969) | 3.90262975 |
| 30 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.90145633 |
| 31 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.86732865 |
| 32 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.83076997 |
| 33 | negative regulation of ligase activity (GO:0051352) | 3.83076997 |
| 34 | DNA strand elongation (GO:0022616) | 3.82567200 |
| 35 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.82340902 |
| 36 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.81189591 |
| 37 | ribosome biogenesis (GO:0042254) | 3.80735039 |
| 38 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.79239877 |
| 39 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.78763590 |
| 40 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.78279014 |
| 41 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.77981848 |
| 42 | cullin deneddylation (GO:0010388) | 3.75101873 |
| 43 | GDP-mannose metabolic process (GO:0019673) | 3.74215504 |
| 44 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.72152102 |
| 45 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.72152102 |
| 46 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.71865559 |
| 47 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.71865559 |
| 48 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.71865559 |
| 49 | regulation of mitochondrial translation (GO:0070129) | 3.71599280 |
| 50 | protein deneddylation (GO:0000338) | 3.70354885 |
| 51 | pseudouridine synthesis (GO:0001522) | 3.68143722 |
| 52 | translational initiation (GO:0006413) | 3.67966575 |
| 53 | cotranslational protein targeting to membrane (GO:0006613) | 3.67266349 |
| 54 | protein targeting to ER (GO:0045047) | 3.64299680 |
| 55 | ribosomal large subunit biogenesis (GO:0042273) | 3.64040715 |
| 56 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.63155935 |
| 57 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.63155935 |
| 58 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.62114976 |
| 59 | tricarboxylic acid cycle (GO:0006099) | 3.61556523 |
| 60 | rRNA modification (GO:0000154) | 3.61378427 |
| 61 | L-methionine salvage (GO:0071267) | 3.59931763 |
| 62 | L-methionine biosynthetic process (GO:0071265) | 3.59931763 |
| 63 | amino acid salvage (GO:0043102) | 3.59931763 |
| 64 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.59135548 |
| 65 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.59135548 |
| 66 | NADH dehydrogenase complex assembly (GO:0010257) | 3.59135548 |
| 67 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.57178143 |
| 68 | viral mRNA export from host cell nucleus (GO:0046784) | 3.56868167 |
| 69 | * translation (GO:0006412) | 3.56772607 |
| 70 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.56305524 |
| 71 | peptidyl-arginine N-methylation (GO:0035246) | 3.56200567 |
| 72 | peptidyl-arginine methylation (GO:0018216) | 3.56200567 |
| 73 | NADH metabolic process (GO:0006734) | 3.55383924 |
| 74 | mitotic nuclear envelope reassembly (GO:0007084) | 3.54223850 |
| 75 | nuclear envelope reassembly (GO:0031468) | 3.54223850 |
| 76 | DNA replication initiation (GO:0006270) | 3.53524613 |
| 77 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.52951962 |
| 78 | cellular component biogenesis (GO:0044085) | 3.50156240 |
| 79 | protein localization to endoplasmic reticulum (GO:0070972) | 3.49056977 |
| 80 | transcription from mitochondrial promoter (GO:0006390) | 3.46193362 |
| 81 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.45263454 |
| 82 | proline metabolic process (GO:0006560) | 3.44706571 |
| 83 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.44624131 |
| 84 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.44333313 |
| 85 | respiratory electron transport chain (GO:0022904) | 3.44163945 |
| 86 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.41312628 |
| 87 | rRNA transcription (GO:0009303) | 3.40893846 |
| 88 | DNA replication checkpoint (GO:0000076) | 3.39483363 |
| 89 | protein complex biogenesis (GO:0070271) | 3.38849072 |
| 90 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.38833293 |
| 91 | telomere maintenance via recombination (GO:0000722) | 3.37616566 |
| 92 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 3.37518255 |
| 93 | spliceosomal snRNP assembly (GO:0000387) | 3.36616831 |
| 94 | electron transport chain (GO:0022900) | 3.35817984 |
| 95 | UTP biosynthetic process (GO:0006228) | 3.34730125 |
| 96 | ncRNA 3-end processing (GO:0043628) | 3.34023350 |
| 97 | rRNA processing (GO:0006364) | 3.33914700 |
| 98 | mitochondrial fusion (GO:0008053) | 3.32390907 |
| 99 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.31830379 |
| 100 | cellular protein complex disassembly (GO:0043624) | 3.31525772 |
| 101 | peptidyl-histidine modification (GO:0018202) | 3.31422282 |
| 102 | metallo-sulfur cluster assembly (GO:0031163) | 3.29908714 |
| 103 | iron-sulfur cluster assembly (GO:0016226) | 3.29908714 |
| 104 | positive regulation of ligase activity (GO:0051351) | 3.29588460 |
| 105 | mitochondrial RNA metabolic process (GO:0000959) | 3.28236242 |
| 106 | 7-methylguanosine mRNA capping (GO:0006370) | 3.26078393 |
| 107 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.26064574 |
| 108 | folic acid metabolic process (GO:0046655) | 3.25400146 |
| 109 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.24965474 |
| 110 | viral life cycle (GO:0019058) | 3.24804990 |
| 111 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 3.22531005 |
| 112 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.21696549 |
| 113 | rRNA metabolic process (GO:0016072) | 3.21683521 |
| 114 | RNA capping (GO:0036260) | 3.17615712 |
| 115 | 7-methylguanosine RNA capping (GO:0009452) | 3.17615712 |
| 116 | protein targeting to mitochondrion (GO:0006626) | 3.17238170 |
| 117 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.16297213 |
| 118 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.15102917 |
| 119 | establishment of protein localization to mitochondrion (GO:0072655) | 3.15034023 |
| 120 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.13564801 |
| 121 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.12614648 |
| 122 | tRNA methylation (GO:0030488) | 3.11544519 |
| 123 | mitotic chromosome condensation (GO:0007076) | 3.10862404 |
| 124 | positive regulation of cell cycle arrest (GO:0071158) | 3.07695979 |
| 125 | telomere maintenance via telomere lengthening (GO:0010833) | 3.06331868 |
| 126 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.05743505 |
| 127 | UTP metabolic process (GO:0046051) | 3.02229787 |
| 128 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.01089032 |
| 129 | pentose metabolic process (GO:0019321) | 3.00561711 |
| 130 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.00556370 |
| 131 | ribosome assembly (GO:0042255) | 3.00371286 |
| 132 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 2.99225446 |
| 133 | cell cycle G1/S phase transition (GO:0044843) | 2.97910931 |
| 134 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.97910931 |
| 135 | L-serine metabolic process (GO:0006563) | 2.97626154 |
| 136 | establishment of integrated proviral latency (GO:0075713) | 2.97468855 |
| 137 | respiratory chain complex IV assembly (GO:0008535) | 2.96415457 |
| 138 | protein insertion into membrane (GO:0051205) | 2.96248479 |
| 139 | regulation of ligase activity (GO:0051340) | 2.94811361 |
| 140 | aerobic respiration (GO:0009060) | 2.94366801 |
| 141 | transcription from RNA polymerase I promoter (GO:0006360) | 2.92731424 |
| 142 | tRNA modification (GO:0006400) | 2.90748876 |
| 143 | COPI coating of Golgi vesicle (GO:0048205) | 2.89832955 |
| 144 | Golgi transport vesicle coating (GO:0048200) | 2.89832955 |
| 145 | negative regulation of mRNA processing (GO:0050686) | 2.86581057 |
| 146 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.85662303 |
| 147 | negative regulation of B cell apoptotic process (GO:0002903) | 2.84884012 |
| 148 | heterochromatin organization (GO:0070828) | 2.83343676 |
| 149 | pentose-phosphate shunt (GO:0006098) | 2.82875237 |
| 150 | CTP metabolic process (GO:0046036) | 2.81736135 |
| 151 | CTP biosynthetic process (GO:0006241) | 2.81736135 |
| 152 | regulation of translational elongation (GO:0006448) | 2.81657860 |
| 153 | GTP biosynthetic process (GO:0006183) | 2.77953987 |
| 154 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.77682018 |
| 155 | base-excision repair (GO:0006284) | 2.75341190 |
| 156 | establishment of viral latency (GO:0019043) | 2.73347739 |
| 157 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.72043459 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.67383755 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.21289160 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.04992152 |
| 4 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.96710995 |
| 5 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.76564971 |
| 6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.54685965 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.54377453 |
| 8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.40972435 |
| 9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.22314988 |
| 10 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.10183151 |
| 11 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.09360013 |
| 12 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.83760776 |
| 13 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.71390248 |
| 14 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.70671601 |
| 15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.44075206 |
| 16 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.41152865 |
| 17 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.37893343 |
| 18 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.33870941 |
| 19 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.32460319 |
| 20 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.29141935 |
| 21 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.26055181 |
| 22 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.24646953 |
| 23 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.22632775 |
| 24 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.20134925 |
| 25 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.16926888 |
| 26 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.15321547 |
| 27 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.14442984 |
| 28 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.13044979 |
| 29 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.10912139 |
| 30 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.08333173 |
| 31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.03125666 |
| 32 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.95655497 |
| 33 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.95022000 |
| 34 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.86577818 |
| 35 | * NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.83515041 |
| 36 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82083457 |
| 37 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.80980193 |
| 38 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.78637975 |
| 39 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.77086740 |
| 40 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.75508794 |
| 41 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74754854 |
| 42 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.72135223 |
| 43 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.71950989 |
| 44 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.69175346 |
| 45 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.67284183 |
| 46 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.63058301 |
| 47 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62653046 |
| 48 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.59370951 |
| 49 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.58406621 |
| 50 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.57967702 |
| 51 | * P68_20966046_ChIP-Seq_HELA_Human | 1.50683894 |
| 52 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.50238166 |
| 53 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.50224307 |
| 54 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.50147454 |
| 55 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.47452757 |
| 56 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.46810674 |
| 57 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.45242419 |
| 58 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.44213410 |
| 59 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.44162692 |
| 60 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.43269291 |
| 61 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41073190 |
| 62 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.40211113 |
| 63 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.39425937 |
| 64 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.39020193 |
| 65 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.35443277 |
| 66 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.31984830 |
| 67 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.29086481 |
| 68 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.28144507 |
| 69 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.28017733 |
| 70 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.22516096 |
| 71 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.22184271 |
| 72 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.22013160 |
| 73 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.21501400 |
| 74 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.21096567 |
| 75 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.20590460 |
| 76 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.19065819 |
| 77 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.18919464 |
| 78 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.18263278 |
| 79 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.16781583 |
| 80 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.16623792 |
| 81 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.16409936 |
| 82 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.15541764 |
| 83 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.14810863 |
| 84 | MYC_22102868_ChIP-Seq_BL_Human | 1.14434833 |
| 85 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.13463669 |
| 86 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.12557435 |
| 87 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.12132490 |
| 88 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.11398329 |
| 89 | MAF_26560356_Chip-Seq_TH2_Human | 1.09177232 |
| 90 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.09095807 |
| 91 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.08652693 |
| 92 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.08585569 |
| 93 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.08576192 |
| 94 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.08344129 |
| 95 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.06956074 |
| 96 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.06939154 |
| 97 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.06465127 |
| 98 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.03465491 |
| 99 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.03005976 |
| 100 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.02851255 |
| 101 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.01930161 |
| 102 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.01694311 |
| 103 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.01010736 |
| 104 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.00032315 |
| 105 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.99943858 |
| 106 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.99456483 |
| 107 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98834965 |
| 108 | MAF_26560356_Chip-Seq_TH1_Human | 0.98286819 |
| 109 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.97656029 |
| 110 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96924554 |
| 111 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.95323453 |
| 112 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94807010 |
| 113 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.94373680 |
| 114 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.94340031 |
| 115 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.93865523 |
| 116 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.93396294 |
| 117 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.93064914 |
| 118 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.92185382 |
| 119 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92019948 |
| 120 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91786105 |
| 121 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.89282445 |
| 122 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.88779472 |
| 123 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.88432915 |
| 124 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.88158674 |
| 125 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.88030969 |
| 126 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.87778504 |
| 127 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.87302050 |
| 128 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.86643461 |
| 129 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.86117491 |
| 130 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.85291584 |
| 131 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.85025978 |
| 132 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84883916 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.79563329 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 3.71251695 |
| 3 | MP0003646_muscle_fatigue | 3.71101030 |
| 4 | MP0003111_abnormal_nucleus_morphology | 3.13200609 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.12032286 |
| 6 | MP0006036_abnormal_mitochondrial_physio | 2.98951388 |
| 7 | MP0010094_abnormal_chromosome_stability | 2.96959918 |
| 8 | MP0004084_abnormal_cardiac_muscle | 2.92675899 |
| 9 | MP0003077_abnormal_cell_cycle | 2.92177133 |
| 10 | MP0008058_abnormal_DNA_repair | 2.65276875 |
| 11 | MP0002837_dystrophic_cardiac_calcinosis | 2.61322282 |
| 12 | MP0002877_abnormal_melanocyte_morpholog | 2.41054805 |
| 13 | MP0003186_abnormal_redox_activity | 2.27317190 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.24415951 |
| 15 | MP0004233_abnormal_muscle_weight | 2.22079847 |
| 16 | MP0008932_abnormal_embryonic_tissue | 2.17290687 |
| 17 | MP0006035_abnormal_mitochondrial_morpho | 2.13638691 |
| 18 | MP0000678_abnormal_parathyroid_gland | 2.09722555 |
| 19 | MP0000749_muscle_degeneration | 2.05316611 |
| 20 | MP0002396_abnormal_hematopoietic_system | 2.03808545 |
| 21 | MP0005330_cardiomyopathy | 2.01343058 |
| 22 | MP0004215_abnormal_myocardial_fiber | 1.96510196 |
| 23 | MP0008007_abnormal_cellular_replicative | 1.95658527 |
| 24 | MP0005501_abnormal_skin_physiology | 1.92173625 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 1.89687608 |
| 26 | MP0003718_maternal_effect | 1.88178655 |
| 27 | MP0004185_abnormal_adipocyte_glucose | 1.88081540 |
| 28 | MP0002163_abnormal_gland_morphology | 1.87598599 |
| 29 | MP0008057_abnormal_DNA_replication | 1.86795048 |
| 30 | MP0003786_premature_aging | 1.85667544 |
| 31 | MP0004036_abnormal_muscle_relaxation | 1.82321557 |
| 32 | MP0000750_abnormal_muscle_regeneration | 1.69028077 |
| 33 | MP0001661_extended_life_span | 1.64959675 |
| 34 | MP0002796_impaired_skin_barrier | 1.63055773 |
| 35 | MP0003221_abnormal_cardiomyocyte_apopto | 1.61238707 |
| 36 | MP0004858_abnormal_nervous_system | 1.60350518 |
| 37 | MP0001730_embryonic_growth_arrest | 1.59555491 |
| 38 | MP0003763_abnormal_thymus_physiology | 1.57779631 |
| 39 | MP0009278_abnormal_bone_marrow | 1.57437939 |
| 40 | MP0001873_stomach_inflammation | 1.50850697 |
| 41 | MP0000003_abnormal_adipose_tissue | 1.49920973 |
| 42 | MP0002132_abnormal_respiratory_system | 1.46515472 |
| 43 | MP0002269_muscular_atrophy | 1.41892511 |
| 44 | MP0003705_abnormal_hypodermis_morpholog | 1.41092892 |
| 45 | MP0000490_abnormal_crypts_of | 1.40380161 |
| 46 | MP0003567_abnormal_fetal_cardiomyocyte | 1.40167355 |
| 47 | MP0000751_myopathy | 1.39738489 |
| 48 | MP0004147_increased_porphyrin_level | 1.39249093 |
| 49 | MP0005671_abnormal_response_to | 1.39096337 |
| 50 | MP0008877_abnormal_DNA_methylation | 1.36288411 |
| 51 | MP0000358_abnormal_cell_content/ | 1.33471775 |
| 52 | MP0000313_abnormal_cell_death | 1.29399250 |
| 53 | MP0005385_cardiovascular_system_phenoty | 1.28992959 |
| 54 | MP0001544_abnormal_cardiovascular_syste | 1.28992959 |
| 55 | MP0001346_abnormal_lacrimal_gland | 1.26058134 |
| 56 | MP0003123_paternal_imprinting | 1.26039685 |
| 57 | MP0008775_abnormal_heart_ventricle | 1.24907597 |
| 58 | MP0002249_abnormal_larynx_morphology | 1.23824838 |
| 59 | MP0001881_abnormal_mammary_gland | 1.21712617 |
| 60 | MP0001764_abnormal_homeostasis | 1.21366104 |
| 61 | MP0002722_abnormal_immune_system | 1.20288757 |
| 62 | MP0009379_abnormal_foot_pigmentation | 1.17638169 |
| 63 | MP0005266_abnormal_metabolism | 1.17615275 |
| 64 | MP0002019_abnormal_tumor_incidence | 1.17470532 |
| 65 | MP0001853_heart_inflammation | 1.17442392 |
| 66 | MP0000350_abnormal_cell_proliferation | 1.17397892 |
| 67 | MP0005670_abnormal_white_adipose | 1.15821350 |
| 68 | MP0002080_prenatal_lethality | 1.14614833 |
| 69 | MP0000689_abnormal_spleen_morphology | 1.14483985 |
| 70 | MP0009785_altered_susceptibility_to | 1.14446956 |
| 71 | MP0002398_abnormal_bone_marrow | 1.14156844 |
| 72 | MP0005076_abnormal_cell_differentiation | 1.13096367 |
| 73 | MP0000343_altered_response_to | 1.12694216 |
| 74 | MP0001697_abnormal_embryo_size | 1.12444794 |
| 75 | MP0003984_embryonic_growth_retardation | 1.11839240 |
| 76 | MP0001835_abnormal_antigen_presentation | 1.11210707 |
| 77 | MP0008260_abnormal_autophagy | 1.11136812 |
| 78 | MP0005623_abnormal_meninges_morphology | 1.11031450 |
| 79 | MP0005397_hematopoietic_system_phenotyp | 1.09947990 |
| 80 | MP0001545_abnormal_hematopoietic_system | 1.09947990 |
| 81 | MP0001672_abnormal_embryogenesis/_devel | 1.08669145 |
| 82 | MP0005380_embryogenesis_phenotype | 1.08669145 |
| 83 | MP0002972_abnormal_cardiac_muscle | 1.07791219 |
| 84 | MP0000747_muscle_weakness | 1.07475488 |
| 85 | MP0001348_abnormal_lacrimal_gland | 1.07463157 |
| 86 | MP0002088_abnormal_embryonic_growth/wei | 1.06071352 |
| 87 | MP0002127_abnormal_cardiovascular_syste | 1.05310439 |
| 88 | MP0002106_abnormal_muscle_physiology | 1.03676177 |
| 89 | MP0003656_abnormal_erythrocyte_physiolo | 1.02382158 |
| 90 | MP0002429_abnormal_blood_cell | 1.01310988 |
| 91 | MP0001727_abnormal_embryo_implantation | 1.00881499 |
| 92 | MP0000703_abnormal_thymus_morphology | 1.00635439 |
| 93 | MP0002089_abnormal_postnatal_growth/wei | 1.00432448 |
| 94 | MP0005075_abnormal_melanosome_morpholog | 0.99279751 |
| 95 | MP0004808_abnormal_hematopoietic_stem | 0.99123466 |
| 96 | MP0000681_abnormal_thyroid_gland | 0.98461268 |
| 97 | MP0004087_abnormal_muscle_fiber | 0.97911480 |
| 98 | MP0005375_adipose_tissue_phenotype | 0.95507822 |
| 99 | MP0005451_abnormal_body_composition | 0.95505572 |
| 100 | MP0009840_abnormal_foam_cell | 0.94235672 |
| 101 | MP0009672_abnormal_birth_weight | 0.92913616 |
| 102 | MP0010030_abnormal_orbit_morphology | 0.92744114 |
| 103 | MP0010630_abnormal_cardiac_muscle | 0.92192693 |
| 104 | MP0003453_abnormal_keratinocyte_physiol | 0.90539540 |
| 105 | MP0006054_spinal_hemorrhage | 0.89794352 |
| 106 | MP0000716_abnormal_immune_system | 0.88816977 |
| 107 | MP0005666_abnormal_adipose_tissue | 0.88228253 |
| 108 | MP0006138_congestive_heart_failure | 0.87072606 |
| 109 | MP0003828_pulmonary_edema | 0.86936735 |
| 110 | MP0010307_abnormal_tumor_latency | 0.86867731 |
| 111 | MP0005319_abnormal_enzyme/_coenzyme | 0.86308289 |
| 112 | MP0000858_altered_metastatic_potential | 0.85979237 |
| 113 | MP0005084_abnormal_gallbladder_morpholo | 0.85960726 |
| 114 | MP0005083_abnormal_biliary_tract | 0.85805822 |
| 115 | MP0002970_abnormal_white_adipose | 0.85543293 |
| 116 | MP0009931_abnormal_skin_appearance | 0.85297509 |
| 117 | MP0000759_abnormal_skeletal_muscle | 0.85217961 |
| 118 | MP0003137_abnormal_impulse_conducting | 0.84226318 |
| 119 | MP0002085_abnormal_embryonic_tissue | 0.82113350 |
| 120 | MP0003724_increased_susceptibility_to | 0.78937223 |
| 121 | MP0005384_cellular_phenotype | 0.78437169 |
| 122 | MP0001849_ear_inflammation | 0.78300069 |
| 123 | MP0009643_abnormal_urine_homeostasis | 0.78040095 |
| 124 | MP0002420_abnormal_adaptive_immunity | 0.77249181 |
| 125 | MP0001216_abnormal_epidermal_layer | 0.76833674 |
| 126 | MP0001819_abnormal_immune_cell | 0.76728026 |
| 127 | MP0005332_abnormal_amino_acid | 0.76315715 |
| 128 | MP0003315_abnormal_perineum_morphology | 0.75655407 |
| 129 | MP0005620_abnormal_muscle_contractility | 0.75041355 |
| 130 | MP0005025_abnormal_response_to | 0.74625287 |
| 131 | MP0000685_abnormal_immune_system | 0.74121561 |
| 132 | MP0002210_abnormal_sex_determination | 0.73752117 |
| 133 | MP0002098_abnormal_vibrissa_morphology | 0.73221002 |
| 134 | MP0001800_abnormal_humoral_immune | 0.72276942 |
| 135 | MP0005369_muscle_phenotype | 0.71756828 |
| 136 | MP0005621_abnormal_cell_physiology | 0.71743426 |
| 137 | MP0002723_abnormal_immune_serum | 0.71128477 |
| 138 | MP0005636_abnormal_mineral_homeostasis | 0.71037223 |
| 139 | MP0010771_integument_phenotype | 0.70725081 |
| 140 | MP0002405_respiratory_system_inflammati | 0.70457310 |
| 141 | MP0002160_abnormal_reproductive_system | 0.68982581 |
| 142 | MP0002332_abnormal_exercise_endurance | 0.68856938 |
| 143 | MP0008995_early_reproductive_senescence | 0.67974917 |
| 144 | MP0000537_abnormal_urethra_morphology | 0.67801091 |
| 145 | MP0002086_abnormal_extraembryonic_tissu | 0.65695780 |
| 146 | MP0000733_abnormal_muscle_development | 0.64975644 |
| 147 | MP0000467_abnormal_esophagus_morphology | 0.64281413 |
| 148 | MP0009697_abnormal_copulation | 0.60530685 |
| 149 | MP0002060_abnormal_skin_morphology | 0.59919253 |
| 150 | MP0000609_abnormal_liver_physiology | 0.59587600 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hepatocellular necrosis (HP:0001404) | 4.95708858 |
| 2 | Hepatic necrosis (HP:0002605) | 4.89388979 |
| 3 | Acute necrotizing encephalopathy (HP:0006965) | 4.71359936 |
| 4 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.63580795 |
| 5 | Mitochondrial inheritance (HP:0001427) | 4.62450655 |
| 6 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.45002432 |
| 7 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.45002432 |
| 8 | Increased CSF lactate (HP:0002490) | 4.37615065 |
| 9 | Abnormal number of erythroid precursors (HP:0012131) | 4.18536493 |
| 10 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.18065361 |
| 11 | Acute encephalopathy (HP:0006846) | 3.98140968 |
| 12 | Increased serum lactate (HP:0002151) | 3.73706816 |
| 13 | Cholecystitis (HP:0001082) | 3.62059888 |
| 14 | Abnormal gallbladder physiology (HP:0012438) | 3.62059888 |
| 15 | Lactic acidosis (HP:0003128) | 3.58358603 |
| 16 | Progressive macrocephaly (HP:0004481) | 3.52801590 |
| 17 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.51211039 |
| 18 | Increased intramyocellular lipid droplets (HP:0012240) | 3.47427452 |
| 19 | Reticulocytopenia (HP:0001896) | 3.47002969 |
| 20 | Lipid accumulation in hepatocytes (HP:0006561) | 3.44207157 |
| 21 | Increased muscle lipid content (HP:0009058) | 3.44164080 |
| 22 | Abnormality of glycolysis (HP:0004366) | 3.37153074 |
| 23 | Increased serum pyruvate (HP:0003542) | 3.37153074 |
| 24 | Increased hepatocellular lipid droplets (HP:0006565) | 3.37046187 |
| 25 | Exercise intolerance (HP:0003546) | 3.31388067 |
| 26 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.26382522 |
| 27 | Respiratory failure (HP:0002878) | 3.26131356 |
| 28 | Birth length less than 3rd percentile (HP:0003561) | 3.22934409 |
| 29 | Cerebral hypomyelination (HP:0006808) | 3.10859725 |
| 30 | Breast hypoplasia (HP:0003187) | 3.03568375 |
| 31 | Cerebral edema (HP:0002181) | 3.00932957 |
| 32 | Multiple enchondromatosis (HP:0005701) | 2.99547803 |
| 33 | Hyperacusis (HP:0010780) | 2.99429475 |
| 34 | 3-Methylglutaconic aciduria (HP:0003535) | 2.97014214 |
| 35 | Oral leukoplakia (HP:0002745) | 2.89702195 |
| 36 | Aplastic anemia (HP:0001915) | 2.89054671 |
| 37 | Type I transferrin isoform profile (HP:0003642) | 2.85932634 |
| 38 | Rhabdomyolysis (HP:0003201) | 2.80829676 |
| 39 | Exertional dyspnea (HP:0002875) | 2.77882899 |
| 40 | Rough bone trabeculation (HP:0100670) | 2.75895757 |
| 41 | CNS demyelination (HP:0007305) | 2.75708150 |
| 42 | Respiratory difficulties (HP:0002880) | 2.73631955 |
| 43 | Palpitations (HP:0001962) | 2.70042713 |
| 44 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.68141718 |
| 45 | Abnormality of alanine metabolism (HP:0010916) | 2.68141718 |
| 46 | Hyperalaninemia (HP:0003348) | 2.68141718 |
| 47 | Macrocytic anemia (HP:0001972) | 2.67462377 |
| 48 | Achilles tendon contracture (HP:0001771) | 2.66989649 |
| 49 | Myopathic facies (HP:0002058) | 2.61345600 |
| 50 | Degeneration of anterior horn cells (HP:0002398) | 2.60453828 |
| 51 | Abnormality of the anterior horn cell (HP:0006802) | 2.60453828 |
| 52 | Ragged-red muscle fibers (HP:0003200) | 2.59978055 |
| 53 | Dicarboxylic aciduria (HP:0003215) | 2.59332532 |
| 54 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.59332532 |
| 55 | Ventricular tachycardia (HP:0004756) | 2.56769910 |
| 56 | Broad distal phalanx of finger (HP:0009836) | 2.56006790 |
| 57 | Emotional lability (HP:0000712) | 2.49408259 |
| 58 | Generalized aminoaciduria (HP:0002909) | 2.48549773 |
| 59 | Nausea (HP:0002018) | 2.45556071 |
| 60 | Hypertensive crisis (HP:0100735) | 2.43247433 |
| 61 | Septate vagina (HP:0001153) | 2.40155217 |
| 62 | Renal Fanconi syndrome (HP:0001994) | 2.39544939 |
| 63 | Microretrognathia (HP:0000308) | 2.39432457 |
| 64 | Carpal bone hypoplasia (HP:0001498) | 2.35571157 |
| 65 | Lethargy (HP:0001254) | 2.32560342 |
| 66 | Truncus arteriosus (HP:0001660) | 2.30692173 |
| 67 | Abnormality of reticulocytes (HP:0004312) | 2.30409772 |
| 68 | Squamous cell carcinoma (HP:0002860) | 2.28161926 |
| 69 | Esophageal neoplasm (HP:0100751) | 2.26631122 |
| 70 | Neoplasm of head and neck (HP:0012288) | 2.26631122 |
| 71 | Pallor (HP:0000980) | 2.25995300 |
| 72 | Progressive muscle weakness (HP:0003323) | 2.24580063 |
| 73 | Abnormality of the Achilles tendon (HP:0005109) | 2.24058129 |
| 74 | Insomnia (HP:0100785) | 2.21830834 |
| 75 | Opisthotonus (HP:0002179) | 2.20550025 |
| 76 | Reticulocytosis (HP:0001923) | 2.19188044 |
| 77 | IgM deficiency (HP:0002850) | 2.17012464 |
| 78 | Hypokinesia (HP:0002375) | 2.14560067 |
| 79 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.14549204 |
| 80 | Unilateral renal agenesis (HP:0000122) | 2.14432475 |
| 81 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.13793601 |
| 82 | Type 2 muscle fiber atrophy (HP:0003554) | 2.13759046 |
| 83 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.13706089 |
| 84 | Microvesicular hepatic steatosis (HP:0001414) | 2.13442451 |
| 85 | Abnormal glycosylation (HP:0012345) | 2.12929573 |
| 86 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.12929573 |
| 87 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.12929573 |
| 88 | Abnormal protein glycosylation (HP:0012346) | 2.12929573 |
| 89 | Unsteady gait (HP:0002317) | 2.12869593 |
| 90 | Muscle fiber atrophy (HP:0100295) | 2.12002415 |
| 91 | Abnormality of the umbilical cord (HP:0010881) | 2.09841753 |
| 92 | Sudden death (HP:0001699) | 2.08746391 |
| 93 | Myoglobinuria (HP:0002913) | 2.08630814 |
| 94 | Cholelithiasis (HP:0001081) | 2.07731510 |
| 95 | Hyperthyroidism (HP:0000836) | 2.06842551 |
| 96 | Premature skin wrinkling (HP:0100678) | 2.04789080 |
| 97 | Premature ovarian failure (HP:0008209) | 2.03550066 |
| 98 | Lipoatrophy (HP:0100578) | 2.03303320 |
| 99 | Gastrointestinal stroma tumor (HP:0100723) | 2.01132818 |
| 100 | Secondary amenorrhea (HP:0000869) | 1.96414163 |
| 101 | Abnormal trabecular bone morphology (HP:0100671) | 1.95969203 |
| 102 | Neoplasm of the adrenal gland (HP:0100631) | 1.94944030 |
| 103 | Leukodystrophy (HP:0002415) | 1.94917166 |
| 104 | Thrombocytosis (HP:0001894) | 1.93308487 |
| 105 | Progressive microcephaly (HP:0000253) | 1.92964326 |
| 106 | Long palpebral fissure (HP:0000637) | 1.91672689 |
| 107 | Hypergonadotropic hypogonadism (HP:0000815) | 1.91337368 |
| 108 | Seborrheic dermatitis (HP:0001051) | 1.91003285 |
| 109 | Abnormality of the gallbladder (HP:0005264) | 1.90939092 |
| 110 | Fasciculations (HP:0002380) | 1.90627292 |
| 111 | Gliosis (HP:0002171) | 1.89927168 |
| 112 | Abnormality of urine glucose concentration (HP:0011016) | 1.89801111 |
| 113 | Glycosuria (HP:0003076) | 1.89801111 |
| 114 | Premature graying of hair (HP:0002216) | 1.89763648 |
| 115 | Pancytopenia (HP:0001876) | 1.87110449 |
| 116 | Reduced antithrombin III activity (HP:0001976) | 1.86710253 |
| 117 | Selective tooth agenesis (HP:0001592) | 1.86654199 |
| 118 | Distal lower limb muscle weakness (HP:0009053) | 1.86501149 |
| 119 | Trismus (HP:0000211) | 1.86125519 |
| 120 | Areflexia of lower limbs (HP:0002522) | 1.85858307 |
| 121 | Hyperglycinuria (HP:0003108) | 1.85023727 |
| 122 | Nonimmune hydrops fetalis (HP:0001790) | 1.84958942 |
| 123 | Neuroendocrine neoplasm (HP:0100634) | 1.83732892 |
| 124 | Dilated cardiomyopathy (HP:0001644) | 1.83109127 |
| 125 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.82070225 |
| 126 | Patellar aplasia (HP:0006443) | 1.80974271 |
| 127 | Methylmalonic aciduria (HP:0012120) | 1.80817204 |
| 128 | Horseshoe kidney (HP:0000085) | 1.79903623 |
| 129 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.79557048 |
| 130 | Single umbilical artery (HP:0001195) | 1.79557048 |
| 131 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.79557048 |
| 132 | Self-mutilation (HP:0000742) | 1.79354380 |
| 133 | Tinnitus (HP:0000360) | 1.77316614 |
| 134 | Proximal tubulopathy (HP:0000114) | 1.77167837 |
| 135 | Poor head control (HP:0002421) | 1.76507533 |
| 136 | Sparse eyelashes (HP:0000653) | 1.76460150 |
| 137 | Optic disc pallor (HP:0000543) | 1.76356499 |
| 138 | Spastic paraparesis (HP:0002313) | 1.76323889 |
| 139 | Deep palmar crease (HP:0006191) | 1.76303037 |
| 140 | Vertebral compression fractures (HP:0002953) | 1.75716037 |
| 141 | Testicular atrophy (HP:0000029) | 1.75513528 |
| 142 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.74915754 |
| 143 | Generalized amyotrophy (HP:0003700) | 1.73648649 |
| 144 | Stridor (HP:0010307) | 1.72717024 |
| 145 | Increased serum ferritin (HP:0003281) | 1.71155725 |
| 146 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.69932576 |
| 147 | Redundant skin (HP:0001582) | 1.69197352 |
| 148 | Prolonged neonatal jaundice (HP:0006579) | 1.68353965 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 5.16025177 |
| 2 | STK16 | 3.89398503 |
| 3 | SMG1 | 3.76469693 |
| 4 | NME2 | 3.65091889 |
| 5 | VRK2 | 3.47721784 |
| 6 | TRIB3 | 3.43923307 |
| 7 | WEE1 | 3.39617981 |
| 8 | EIF2AK1 | 3.17224180 |
| 9 | BCKDK | 2.95444241 |
| 10 | EEF2K | 2.76197713 |
| 11 | KDR | 2.47479734 |
| 12 | TESK2 | 2.40928576 |
| 13 | PIM2 | 2.35316811 |
| 14 | TSSK6 | 2.34482025 |
| 15 | NEK1 | 2.27599159 |
| 16 | ICK | 2.06643652 |
| 17 | PLK4 | 2.04159883 |
| 18 | MYLK | 1.98707154 |
| 19 | EIF2AK3 | 1.69757498 |
| 20 | CDC7 | 1.68379851 |
| 21 | VRK1 | 1.64788838 |
| 22 | PRPF4B | 1.63818394 |
| 23 | SIK1 | 1.63489864 |
| 24 | BRSK2 | 1.62304866 |
| 25 | SRPK1 | 1.62091170 |
| 26 | MAP3K11 | 1.61716640 |
| 27 | MAP4K1 | 1.61044409 |
| 28 | ARAF | 1.56299090 |
| 29 | ZAK | 1.54475537 |
| 30 | NME1 | 1.49573071 |
| 31 | CDK12 | 1.44351763 |
| 32 | BRAF | 1.35325640 |
| 33 | ACVR1B | 1.34172516 |
| 34 | TLK1 | 1.31672688 |
| 35 | PDK3 | 1.29310146 |
| 36 | PDK4 | 1.29310146 |
| 37 | NEK2 | 1.25626952 |
| 38 | OBSCN | 1.19771355 |
| 39 | PLK1 | 1.19261587 |
| 40 | PDK2 | 1.16274287 |
| 41 | RPS6KA4 | 1.15594419 |
| 42 | MAP3K12 | 1.12877530 |
| 43 | TESK1 | 1.12086378 |
| 44 | BRSK1 | 1.11924694 |
| 45 | AURKB | 1.08505098 |
| 46 | TTK | 1.07667247 |
| 47 | MAPK11 | 1.06687251 |
| 48 | TGFBR1 | 1.06150309 |
| 49 | CCNB1 | 1.04148292 |
| 50 | PRKD3 | 1.02028923 |
| 51 | AURKA | 0.95179413 |
| 52 | MAPKAPK3 | 0.94838378 |
| 53 | MUSK | 0.93680800 |
| 54 | TAF1 | 0.93272853 |
| 55 | IRAK4 | 0.93204636 |
| 56 | CDK7 | 0.92566408 |
| 57 | ILK | 0.92026782 |
| 58 | PBK | 0.90395023 |
| 59 | TIE1 | 0.89685504 |
| 60 | DYRK3 | 0.88454386 |
| 61 | FLT3 | 0.86208355 |
| 62 | AKT3 | 0.85911920 |
| 63 | ZAP70 | 0.85391772 |
| 64 | PAK4 | 0.85385966 |
| 65 | RPS6KB2 | 0.85383879 |
| 66 | EPHA2 | 0.82961509 |
| 67 | CDK19 | 0.81509098 |
| 68 | LRRK2 | 0.79498097 |
| 69 | STK24 | 0.79135523 |
| 70 | IRAK3 | 0.76683253 |
| 71 | MAP3K10 | 0.75753482 |
| 72 | ATR | 0.75011862 |
| 73 | AKT2 | 0.73902984 |
| 74 | MAP3K13 | 0.73771312 |
| 75 | DAPK3 | 0.73299154 |
| 76 | TAOK2 | 0.72511615 |
| 77 | MAP2K2 | 0.71271813 |
| 78 | STK4 | 0.70105715 |
| 79 | PIM1 | 0.68558545 |
| 80 | PLK3 | 0.67747449 |
| 81 | LIMK1 | 0.65593986 |
| 82 | MAP3K8 | 0.65540527 |
| 83 | TBK1 | 0.63535991 |
| 84 | PAK1 | 0.62532598 |
| 85 | CSNK2A1 | 0.61789545 |
| 86 | CDK8 | 0.61690954 |
| 87 | MAP2K3 | 0.61406055 |
| 88 | CSNK1G3 | 0.60669542 |
| 89 | TXK | 0.60507603 |
| 90 | PASK | 0.60132712 |
| 91 | STK38L | 0.58727016 |
| 92 | SIK2 | 0.58629849 |
| 93 | PINK1 | 0.57948236 |
| 94 | TEC | 0.57594665 |
| 95 | MAP3K9 | 0.57393026 |
| 96 | DAPK1 | 0.57265842 |
| 97 | PRKCI | 0.56244207 |
| 98 | ABL2 | 0.56226790 |
| 99 | CDK4 | 0.55843513 |
| 100 | TTN | 0.55801778 |
| 101 | BLK | 0.54339757 |
| 102 | KIT | 0.54062216 |
| 103 | IRAK2 | 0.52993572 |
| 104 | CSNK2A2 | 0.52032316 |
| 105 | MTOR | 0.51928692 |
| 106 | CDK9 | 0.51050094 |
| 107 | MKNK1 | 0.48303859 |
| 108 | CHEK2 | 0.48029281 |
| 109 | MST1R | 0.47837198 |
| 110 | STK10 | 0.47576528 |
| 111 | TYK2 | 0.47406932 |
| 112 | LMTK2 | 0.47211339 |
| 113 | RAF1 | 0.46918404 |
| 114 | MAP2K6 | 0.46452761 |
| 115 | PDPK1 | 0.46150173 |
| 116 | SCYL2 | 0.45724603 |
| 117 | ERN1 | 0.45105253 |
| 118 | MAP3K3 | 0.43774935 |
| 119 | MAP3K1 | 0.42737350 |
| 120 | CDK2 | 0.42551639 |
| 121 | MAPKAPK5 | 0.42533203 |
| 122 | BTK | 0.42461880 |
| 123 | MAPKAPK2 | 0.42443830 |
| 124 | PKN2 | 0.41639788 |
| 125 | IKBKB | 0.39439781 |
| 126 | HIPK2 | 0.38511811 |
| 127 | PRKD2 | 0.37785072 |
| 128 | SYK | 0.37037081 |
| 129 | BMX | 0.36479587 |
| 130 | ALK | 0.36132452 |
| 131 | CDK11A | 0.35866338 |
| 132 | RPS6KA5 | 0.34937940 |
| 133 | EIF2AK2 | 0.34561096 |
| 134 | MST4 | 0.34118234 |
| 135 | CHEK1 | 0.33997565 |
| 136 | MOS | 0.33558809 |
| 137 | CDK1 | 0.32199716 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.47774673 |
| 2 | * Ribosome_Homo sapiens_hsa03010 | 4.05942634 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.81760591 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 3.70541042 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.29498825 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.06821431 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 3.03724470 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.88608789 |
| 9 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.77922211 |
| 10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.59367369 |
| 11 | Base excision repair_Homo sapiens_hsa03410 | 2.42744426 |
| 12 | Spliceosome_Homo sapiens_hsa03040 | 2.40526758 |
| 13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.32159509 |
| 14 | Huntingtons disease_Homo sapiens_hsa05016 | 2.17159187 |
| 15 | Homologous recombination_Homo sapiens_hsa03440 | 2.14662792 |
| 16 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.07053837 |
| 17 | RNA transport_Homo sapiens_hsa03013 | 2.02836790 |
| 18 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.76254674 |
| 19 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.73065124 |
| 20 | Alzheimers disease_Homo sapiens_hsa05010 | 1.72426305 |
| 21 | Carbon metabolism_Homo sapiens_hsa01200 | 1.62749795 |
| 22 | Protein export_Homo sapiens_hsa03060 | 1.59899128 |
| 23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.58003422 |
| 24 | Purine metabolism_Homo sapiens_hsa00230 | 1.48524155 |
| 25 | RNA degradation_Homo sapiens_hsa03018 | 1.44910798 |
| 26 | Cell cycle_Homo sapiens_hsa04110 | 1.38988286 |
| 27 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.36172642 |
| 28 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.35485930 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.34400154 |
| 30 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.30782603 |
| 31 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.30659382 |
| 32 | Basal transcription factors_Homo sapiens_hsa03022 | 1.29609928 |
| 33 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.28374859 |
| 34 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.24119359 |
| 35 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.21208547 |
| 36 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.17293559 |
| 37 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.15502131 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.12365633 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.08488856 |
| 40 | Bladder cancer_Homo sapiens_hsa05219 | 1.08191496 |
| 41 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.04900016 |
| 42 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.03721900 |
| 43 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.03682598 |
| 44 | Sulfur relay system_Homo sapiens_hsa04122 | 1.02356199 |
| 45 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.95390920 |
| 46 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.94202435 |
| 47 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.93254662 |
| 48 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.87104490 |
| 49 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.86704488 |
| 50 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.85759851 |
| 51 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.85489788 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.78944900 |
| 53 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.77168100 |
| 54 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.75530208 |
| 55 | Galactose metabolism_Homo sapiens_hsa00052 | 0.72411593 |
| 56 | Metabolic pathways_Homo sapiens_hsa01100 | 0.71548132 |
| 57 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.67921786 |
| 58 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.66264855 |
| 59 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.65902263 |
| 60 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.65321033 |
| 61 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.62538275 |
| 62 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.62434633 |
| 63 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.61477094 |
| 64 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.61165229 |
| 65 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.60953024 |
| 66 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57609679 |
| 67 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.55073846 |
| 68 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.53469297 |
| 69 | Legionellosis_Homo sapiens_hsa05134 | 0.53251459 |
| 70 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.53085107 |
| 71 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.52000106 |
| 72 | Prion diseases_Homo sapiens_hsa05020 | 0.51216692 |
| 73 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.49507296 |
| 74 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.49019563 |
| 75 | Alcoholism_Homo sapiens_hsa05034 | 0.48254088 |
| 76 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.46708845 |
| 77 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.45594967 |
| 78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45587259 |
| 79 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.43252253 |
| 80 | Other glycan degradation_Homo sapiens_hsa00511 | 0.42554719 |
| 81 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.41783053 |
| 82 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.41558528 |
| 83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.41028585 |
| 84 | Peroxisome_Homo sapiens_hsa04146 | 0.40510303 |
| 85 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.34516495 |
| 86 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.32910043 |
| 87 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32250487 |
| 88 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.30931416 |
| 89 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.30278515 |
| 90 | Lysine degradation_Homo sapiens_hsa00310 | 0.26747514 |
| 91 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.24211322 |
| 92 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.23946490 |
| 93 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.23280363 |
| 94 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.22365033 |
| 95 | HTLV-I infection_Homo sapiens_hsa05166 | 0.22300066 |
| 96 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.22075142 |
| 97 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.21059984 |
| 98 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.21020192 |
| 99 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.20478428 |
| 100 | Measles_Homo sapiens_hsa05162 | 0.19618270 |
| 101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.19373863 |
| 102 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.19119864 |
| 103 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.19095566 |
| 104 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.18969253 |
| 105 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.18965871 |
| 106 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.18399744 |
| 107 | Thyroid cancer_Homo sapiens_hsa05216 | 0.18219273 |
| 108 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.18160492 |
| 109 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.17516749 |
| 110 | Lysosome_Homo sapiens_hsa04142 | 0.17425876 |
| 111 | Viral myocarditis_Homo sapiens_hsa05416 | 0.16992875 |
| 112 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.16958626 |
| 113 | Shigellosis_Homo sapiens_hsa05131 | 0.15603477 |
| 114 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.15387648 |
| 115 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.15152592 |
| 116 | Apoptosis_Homo sapiens_hsa04210 | 0.14687576 |
| 117 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.14278943 |
| 118 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.13094467 |
| 119 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.08420461 |
| 120 | Allograft rejection_Homo sapiens_hsa05330 | 0.08185360 |
| 121 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.08109624 |
| 122 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.04207933 |
| 123 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.03447735 |
| 124 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.03237529 |
| 125 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.03017087 |
| 126 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.01584672 |

